News archive

Efficacy and safety of ethylmethylhydroxypyridine succinate in patients with ischemic stroke

Stroke is still the most significant problem of the modern medicine and the leading cause of mortality and morbidity.

Read More

The efficacy of ethylmethylhydroxypyridine succinate in patients with cerebrovascular pathology complicated with diabetes mellitus and metabolic syndrome

Arterial hypertension, diabetes mellitus, obesity and dyslipidemia continue to be the main risk factors for diseases of the circulatory system and the leading causes of mortality in the world, the combination of these diseases significantly increases the likelihood of the development and more rapid progression of cardiovascular and cerebrovascular pathology.

Read More

Effectiveness and safety of mexidol forte 250 in the sequential therapy in patients with chronic ischemia

Objective. To study of efficacy and safety of mexidol used as intravenous infusion for 14 days, followed by per os treatment with mexidol FORTE 250 for 60 days in patients with chronic brain ischemia (CHM) complicated with arterial hypertension and atherosclerosis.

Read More